{"altmetric_id":4692461,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Fuda Cancer Hospital, Guangzhou"],"first_seen_on":"2015-10-28T14:51:36+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1420644000,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02333773?lup_d=30&lup_s=12%2F08%2F2014&recr=Open&term=cancer","http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02333773?term=kidney+cancer&amp%3Blup_s=12%2F08%2F2014&amp%3Blup_d=30"],"nct_id":"NCT02333773","pubdate":"2015-01-06T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli","type":"clinical_trial_study_record"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":5032658,"mean":5.9650115992388,"rank":4190854,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":5032658,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":189577,"mean":10.100416687766,"rank":148954,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":189577,"percentile":1},"this_journal":{"total_number_of_other_articles":13245,"mean":5.0504329507702,"rank":11379,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":13245,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":691,"mean":6.2982463768116,"rank":560,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":691,"percentile":1}}},"demographics":[],"counts":{"total":{"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["170969349605028"],"posts_count":1}},"posts":{"facebook":[{"title":"Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli","url":"https:\/\/www.facebook.com\/170969349605028\/posts\/792186157483341","license":"public","citation_ids":[4692461],"posted_on":"2015-01-07T15:20:00+00:00","summary":"Condition: Liver Cancer\nInterventions: Procedure: Irreversible electroporation (IRE); Device: NanoKnife\nSponsor: Fuda Cancer Hospital, Guangzhou\nRecruiting - verified January 2015","author":{"name":"Kidney Cancer News","url":"https:\/\/www.facebook.com\/170969349605028","facebook_wall_name":"Kidney Cancer News","image":"https:\/\/graph.facebook.com\/170969349605028\/picture","id_on_source":"170969349605028"}}]}}